Low digestible carbohydrates (polyols and lactose): Significance of adrenal medullary proliferative lesions in the rat

Regulatory Toxicology and Pharmacology

Volumn 23, Issue 3, 1996, Pages 256-297

  Lynch, B S ^a   Tischler, A S ^b   Capen, C ^c   Munro, I C ^a   McGirr, L M ^a   McClain, R M ^d  

^a CanTox Inc   (Canada)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c OHIO STATE UNIVERSITY   (United States)

^d HOFFMANN LA ROCHE INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOHYDRATE; FRUCTOSE; ISOMALT; LACTITOL; LACTOSE; MALTITOL; MANNITOL; POLYOL; SORBITOL; XYLITOL;

ADRENAL DISEASE; ADRENAL MEDULLA; ANIMAL EXPERIMENT; ANIMAL MODEL; NONHUMAN; PRIORITY JOURNAL; RAT; REVIEW;

EID: 0030174837     PISSN: 02732300     EISSN: None     Source Type: Journal    
DOI: 10.1006/rtph.1996.0055     Document Type: Article

References (146)

1. Allen, L. H. (1982). Calcium bioavailability and absorption: A review. Am. J. Clin. Nutr. 35, 783-808.
2. Allison, R. G. (1979). Dietary Sugars in Health and Disease. III. Sorbitol. Prepared for the Bureau of Foods, Food and Drug Administration by Life Sciences Research Office, Federation of American Societies for Experimental Biology, Bethesda, MD.
3. Amman, P., Rizzoli, R., and Fleisch, H. (1988). Influence of the disaccharide lactitol on intestinal absorption and body retention of calcium in rats. J. Nutr. 118, 793-795.
4. Anderson, D. J. (1993). Molecular control of the cell fate in the neural crest; The sympathoadrenal lineage. Annu. Rev. Neurosci. 16,129-158.
5. Atsuji, H., Asano, S., and Hayashi, S. (1982). A study on the metabolism of maltitol, a disaccharide alcohol. Unpublished report from Keio University, Japan. [Submitted by Anic S.p.A. Cited in JECFA, 1987b]
6. Bär, A. (1983). Clinico-chemical investigations in Hungarian children participating in a WHO caries prevention programme with xylitol. Internal Research Report No. B-106'614 of Hoffman-La Roche & Co. Ltd., Basel, Switzerland. [Cited in Bär, 1987a]
7. Bär, A. (1984a). Effects of chronic xylitol and sorbitol ingestion on the adrenal medulla of male Fuellinsdorf-Albino rats. Internal Research Report No. B-106 633.
8. Bär, A. (1984b). Clinico-chemical investigations in Hungarian children participating in a WHO caries prevention programme with xylitol. Interim results after two years of treatment. Internal Research Report No. B-106'636 of Hoffmann-La Roche & Co. Ltd., Basel, Switzerland. [Cited in Bär, 1987a]
9. Bär, A. (1985). Effect of high oral doses of xylitol versus sucrose on urinary risk factors of urolithiasis in man. Int. J. Vit Nutr. Res. (Suppl. 28), 91-118.
10. Bär, A. (1986). Adrenomedullary tumors in xylitol-fed rats: Dietary levels of calcium as a determinant factor. Final study report prepared for Xyrofin (UK) Ltd., August 13, 1986. Research Report No. B-44122. Bioresco Ltd., Basel, Switzerland.
11. Bär, A. (1987a). Xylitol. Scientific dossier prepared for submission to the Japanese Ministry of Health and Welfare. Bioresco, Bioresearch Management and Consulting Ltd., Basel, Switzerland.
12. Bär, A. (1987b). Toxicological aspects of sugar alcohols - Studies with Xylitol. In Low Digestibility Carbohydrates (D. C. Leegwater, V. J. Feron, and R. J. J. Hermus, Eds.), pp. 42-50. Proceedings of TNO-CIVO workshop, Zeist, Netherlands, Pudoc Wageningen.
13. Bär, A. (1988). Sugars and adrenal proliferative lesions: the effects of lactose and various polyalcohols. J. Am. Coll. Toxicol. 7(1), 71-81.
14. Bär, A. (1990). Factorial calculation model for the estimation of the physiological caloric value of polyols. In Proceedings of the International Symposium on Caloric Evaluation of Carbohydrates (N. Hosoya, Ed.), pp. 209-257. Research Foundation for Sugar Metabolism, Tokyo, Japan.
15. Bär, A. (1994). Mechanistic considerations in adrenal gland hyperplasia and neoplasia: The calcium hypothesis. Presentation made at the Toxicology Forum Symposium on Overview of Rodent Tumors: Pheochromocytoma and Leydig Cell Tumors, Washington, DC.
16. Bär, A., and Lamm, P. (1986). Clinico-chemical investigations in Polynesian children participating in a WHO caries prevention programme with xylitol: Results of the final examination, p. 169. Report of Hoffman-La Roche & Co. Ltd., Basel, Switzerland. [Cited in Bär, 1987a]
17. Bassler, K. H. (1969). Adaptive processes concerned with the absorption and metabolism of xylitol. In International Symposium on Metabolism, Physiology, and Clinical Use of Pentoses and Pentitols (B. L. Horecker, K. Lang, and Y. Takagi, Eds.), pp. 190-196. Springer-Verlag, Berlin.
18. Berridge, M. J. (1993). Inositol triphosphate and calcium signaling. Nature 361, 315-325.
19. Bosland, M. C., and Bär, A. (1984). Some functional characteristics of adrenal medullary tumors in aged male Wistar rats. Vet. Pathol. 21, 129-140.
20. Brink, E. J., van Beresteijn, E. C. H., Dekker, P. R., and Beynen, A. C. (1993). Urinary excretion of magnesium and calcium as an index of absorption is not affected by lactose intake in healthy adults. Br. J. Nutr. 69, 863-870.
21. Brion, F., and Dupuis, Y. (1980). Calcium and monoamine regulation: Role of vitamin D nutrition. Can. J. Physiol. Pharmacol. 58, 1431-1434.
22. Brommage, R., Binacua, C., Antille, S., and Carrier, A. L. (1993). Intestinal calcium absorption in rats is stimulated by dietary lactulose and other resistant sugars. J. Nutr. 123, 186-194.
23. Brown, W. J., Bärajas, L., and Latta, H. (1971). The ultrastructure of the human adrenal medulla: With comparative studies of white rat. Anat. Rec. 169, 173-184.
24. Capen, C. C., DeLellis, R. A., and Yarrington, J. T. (1991). III. Adrenal medulla. In Handbook of Toxicologic Pathology (W. M. Haschek and C. G. Rousseaux, Eds.), pp. 692-697. Academic Press, New York.
25. Cheng, L. (1980). Pheochromocytoma in rats: Incidence, etiology, morphology and functional activity. J. Environ. Pathol. Toxicol. 4, 219-228.
26. Clapham, D. E. (1995). Calcium signaling. Cell 80, 259-268.
27. Cochet, B., Jung, A., Griessen, M., Bärtoldi, P., Schaller, P., and Donath, A. (1983). Effects of lactose on intestinal calcium absorption in normal and lactase-deficient subjects. Gastroenterology 84, 935-940.
28. Condon, J. R., Nassim, J. R., Millard, F. J. C., Hilbe, A., and Stainthorpe, E. M. (1970). Calcium and phosphorus metabolism in relation to lactose tolerance. Lancet 7649, 1027-1029.
29. Conz, A., and Fumero, S. (1989). Combined chronic toxicity/carcinogenicity study in Sprague-Dawley Crl:CD(SD)BR rats treated with the test article MALBIT® (crystal powder) administered at the dosages of 0, 0.5, 1.5 and 4.5 g/kg/day in the diet; chronic toxicity study. Unpublished report from RBM, Istituto di Richerche Biomediche, Ivrea, Italy. [Submitted to WHO by Cerestar Research and Development, Vilvoorde, Belgium. Cited in JECFA, 1993]
30. Conz, A., and Maraschin, R. (1992). Combined chronic toxicity/carcinogenicity study in Sprague-Dawley Crl:CD(SD)BR rats treated with the test article MALBIT® (crystal powder) administered at the dosages of 0, 0.5, 1.5 and 4.5 g/kg/day in the diet; carcinogenicity study. Unpublished report from RBM, Istituto di Richerche Biomediche, Ivrea, Italy. [Submitted to WHO by Cerestar Research and Development, Vilvoorde, Belgium. Cited in JECFA, 1993]
31. Coupland, R. E. (1969). The Natural History of the Chromaffin Cell, Longmans Green Ltd., Edinburgh, UK.
32. Coupland, R. E. (1989). The natural history of the chromaffin cell, twenty-five years on the beginning. Arch. Histol. Cytol. 52(Suppl.), 331-341. [Cited in Tischler and Coupland, 1994]
33. Coupland, R. E., Kobayashi, S., and Tomlinson, A. (1977). On the presence of small granule chromaffin cells (SGC) in the rodent adrenal medulla. J. Anat. 124, 488-489.
34. 2+ dependent regulation of a ryanodine-insensitive oscillator. J. Biol. Chem. 268, 15213-15220.
35. de Groot, A. P., Lina, B. A. R., Hagenaars, A. J. M., Hollanders, V. M. H., Andringa, M., and Feron, V. J. (1995). Effects of dietary load of acid or base on changes induced by lactose in rats. Food Chem. Toxicol. 33, 1-14.
36. Diener, R. M. (1988). Case history. Pheochromocytomas and Reserpine: Review of carcinogenicity bioassay. J. Am. Coll. Toxicol. 7(1), 95-105.
37. Dills, W. L., Jr. (1989). Sugar alcohols as bulk sweeteners. Annu. Rev. Nutr. 9, 161-186.
38. Doorenbos, H. (1977). Metabolism of lactitol. Unpublished report from the University of Groningen, submitted by CCA to WHO. [Cited in JECFA, 1983]
39. Duprat, P., Snell, K. C., and Hollander, C. F. (1990). Tumours of the adrenal gland. In Pathology of Tumours in Laboratory Animals. Volume 1. Tumours of the Rat (V. Turusov and U. Mohr, Eds.), 2nd ed., No. 99. pp. 573-581. International Agency for Research on Cancer (WHO), International Life Sciences Institute, Lyon, France.
40. Egger, B., Arnerea, V., Llull, J. B., and Lauterburg, B. H. (1989). Effect of one month of lactitol treatment on calcium metabolism in man. Eur. J. Clin. Pharmacol. 37, 205-207.
41. Federation of American Societies for Experimental Biology (FASEB) (1978). Dietary Sugars in Health and Disease II. Xylitol, pp. 48. Prepared for Bureau of Foods, Food and Drug Administration, Life Sciences Research Office, FASEB, Bethesda, MD.
42. Federation of American Societies for Experimental Biology (FASEB) (1986). Health Aspects of Sugar Alcohols and Lactose, Task Order No. 7, Contract No. FDA 223832020. Prepared for Center for Food Safety and Applied Nutrition, Food and Drug Administration, Department of Health and Human Services, Washington, DC 20204. Life Sciences Research Office, FASEB, Bethesda, MD.
43. Federation of American Societies for Experimental Biology (FASEB) (1994). The Evaluation of the Energy of Certain Sugar Alcohols Used as Food Ingredients. Prepared for Calorie Control Council, 5775 Peachtree-Dunwoody Road, Atlanta, Georgia, 30342. Life Sciences Research Office, FASEB, Bethesda, MD.
44. Fischer-Colbrie, R., and Frischenschlager, I. (1985). Immunological characterization of secretory proteins of chromaffin granules: Chromogranins A, chromogranins B, and enkephalin-containing peptides. J. Neurochem. 44, 1854-1861.
45. Förster, H., Quadbeck, R., and Gottstein, U. (1981). Metabolic tolerance to high doses of oral xylitol in human volunteers not previously adapted to xylitol. In Xylitol. Clinical Investigations in Humans (O. Raunhardt and G. Ritzel, Eds.), Supplement No. 22. International Journal for Vitamin and Nutrition Research. Hans Huber Publishers, Bern.
46. Fournier, P. L., Gambier, J., and Fontaine, N. (1967). Effets d'une ingestion prolongée de sorbitol sur l'utilisation du calcium et sur l'ossification du Rat. C. R. Acad. Sci. 9, 1301-1304.
47. Francis, R. M., Peacock, M., Bärkworth, S. A., and Marchal, D. H. (1986). A comparison of the effect of sorbitol and glucose on calcium absorption in post-menopausal women. Am. J. Clin. Nutr. 43, 72-76.
48. Gandia, L., and Garcia, A. G. (1995). Heterogeneity of calcium channels in chromaffin cells from different species: Relevance to secretion, S. 13. Abstracts of the 8th International Symposium on Chromaffin Cell Biology, Edinburgh, UK.
49. Ghosh, A., and Greenberg, M. E. (1995). Calcium signaling in neurons: Molecular mechanisms and cellular consequences. Science 268, 239-247.
50. Goda, T., Yamada, M., Takase, S., and Hosoya, N. (1992). Effect of maltitol intake on intestinal calcium absorption in the rat. J. Nutr. Sci. Vitaminol. 38, 277-286.
51. Gongwer, L. E., Ausletta, C. S., Rinehart, W. E., and Brown, W. R. (1978). Mannitol II: Lifetime Feeding Study of A-132-01320 in Three Strains of Female Rats. Report of ICI Americas Inc., Wilmington, DE, and Bio/dynamics Inc., East Millstone, NJ [Cited in FASEB, 1986]
52. Greenwald, E., Samachson, J., and Spencer, H. (1963). Effect of lactose consumption on calcium metabolism in man. J. Nutr. 79, 531-538.
53. Griessen, M., Speich, P. V., Infante, F., Bärtholdi, P., Cochet, A., Donath, A., Courvoisier, B., and Bonjour, J-Ph. (1989). Effect of absorbable and nonabsorbable sugars on intestinal calcium absorption in humans. Gastroenterology 96, 769-775.
54. Grupp, U., and Siebert, G. (1978). Metabolism of hydrogenated palatinose, an equimolar mixture of α-D-glucopyranosido-1,6-sorbitol and α-D-glucopyranosido-1,6-mannitol. Res. Exp. Med. 173, 261-278.
55. Hämäläinen, M. M., and Mäkinen, K. K. (1989). Polyol-mineral interactions in the diet of the rat with special reference to the stabilities of polyol-metal complexes. Nutr. Res. 9, 801-811.
56. Hämäläinen, M. M., Mäkinen, K. K., Parviainen, M. T., and Koskinen, T. (1985). Peroral xylitol increases intestinal calcium absorption in the rat independently of vitamin D action. Miner. Electrolyte Metab. 11, 178-181.
57. Hamlin, M. H., and Banas, D. A. (1990). Adrenal gland. In Pathology of the Fischer Rat: Reference and Atlas (G. A. Boorman, S. L. Eustis, M. R. Elwell, C. A. Montgomery, Jr., and W. F. MacKenzie, Eds.), pp. 501-518. Academic Press, New York.
58. Harju, M. (1988a). Lactitol as a substrate for beta-galactosidases. I. Literature review and methods. Milchwissenschaft 43(2), 76-78.
59. Harju, M. (1988b). Lactitol as a substrate for beta-galactosidases II. Results and discussion, Milchwissenschaft 43(3), 76-78.
60. Heywood, R., Chesterman, H., Allen, T. R., Sheet, A. E., Kennedy, S. J., Majeed, S. K., and Prentice, D. E. (1977). Xylitol toxicity study in the beagle dog. Unpublished report from Huntingdon Research Center, Huntingdon, Cambridgeshire, UK, for Hoffman-La Roche & Co. Ltd., Basel, Switzerland.
61. Heywood, R., et al. (1981). Revised report: Xylitol toxicity study in the beagle dog. Unpublished report from Huntingdon Research Center, Huntingdon, Cambridgeshire, UK, for Hoffman-La Roche & Co. Ltd., Basel, Switzerland. [Cited in JECFA, 1983]
62. Hoffmann, K., Luckhaus, G., and Müller, L. (1981). Bay i 3939 (Palatinit®) chronic toxicity in dogs by oral administration (a 12-months' feeding study). Unpublished pharmaceutical report No. 10299 from Bayer A. G., Wuppertal, FRG. [Submitted to WHO by Bayer A. G. Cited in JECFA, 1987b]
63. Hunter, B., Colley, J., Street, A., Heywood, R., Prentice, D., and Magnusson, G. (1978a). Xylitol tumorigenicity and toxicity study in long-term dietary administration to rats. Unpublished report from Huntingdon Research Center, Huntingdon, Cambridgeshire, UK, for Hoffman-La Roche Co. Ltd., Basel, Switzerland. [Submitted to WHO/FAO]
64. Hunter, B., Graham, C., Heywood, R., Prentice, D., Roe, R., and Voakes, D. (1978b). Tumorigenicity and carcinogenicity study with xylitol in long-term dietary administration to mice. Unpublished report from Huntingdon Research Center, Huntingdon, Cambridgeshire, UK, for Hoffman-La Roche Co. Ltd., Basel, Switzerland. [Submitted to WHO/FAO. Cited in JECFA, 1978b]
65. Itoya, N., Moriuchi, S., and Hosoya, N. (1974). Effect of oral administration of maltitol on human serum composition. J. Jpn. Soc. Food Nutr. 27, 77-81. [Cited in JECFA, 1987b]
66. Iwakura, K., Tamura, H., Watanabe, M., and Sumi, N. (1994). Mutagenicity studies of lactitol (NS-4). J. Toxicol. Sci. 19(3), 487-497.
67. Joint Expert Committee on Food Additives (JECFA) (1964). Specifications for the Identity and Purity of Food Additives and their Toxicological Evaluation: Emulsifiers, Stabilizers, Bleaching and Maturing Agents. 7th Report of the Joint Food and Agriculture Organization of the United Nations (FAO)/World Health Organization (WHO) Expert Committee on Food Additives. FAO Nutrition Meetings Series No. 35, WHO Technical Report Series No. 281. WHO, Geneva, Switzerland. [Cited in JECFA, 1974a]
68. Joint Expert Committee on Food Additives (JECFA) (1967). Toxicological Evaluation of Some Antimicrobials, Antioxidants, Emulsifiers, Stabilizers, Flour-Treatment Agents, Acids and Bases. FAO Nutrition Meeting Series Nos. 40A, B, C. World Health Organization (WHO), Geneva, Switzerland. [Cited in JECFA, 1974a]
69. Joint Expert Committee on Food Additives (JECFA) (1974a). Toxicological Evaluation of Certain Food Additives. World Health Organization 17th Report of the Joint Food and Agriculture Organization of the United Nations (FAO)/World Health Organization (WHO) Expert Committee on Food Additives. FAO Nutrition Meetings Series No. 53A, WHO Technical Report Series No. 559. WHO, Geneva, Switzerland.
70. Joint Expert Committee on Food Additives (JECFA) (1974b). Evaluation of Certain Food Additives. 18th Report of the Joint Food and Agriculture Organization of the United Nations (FAO)/World Health Organization (WHO) Expert Committee on Food Additives. FAO Nutrition Meetings Series No. 54, WHO Technical Report Series No. 557. WHO, Geneva, Switzerland.
71. Joint Expert Committee on Food Additives (JECFA) (1978a). Summary of Toxicological Data of Certain Food Additives and Contaminants. 22nd Report of the Joint Food and Agriculture Organization of the United Nations (FAO)/World Health Organization (WHO) Expert Committee on Food Additives. WHO Food Additives Series No. 13, WHO Technical Report Series No. 631. WHO, Geneva, Switzerland.
72. Joint Expert Committee on Food Additives (JECFA) (1978b). Evaluation of Certain Food Additives. 21st Report of the Joint Food and Agriculture Organization of the United Nations (FAO)/World Health Organization (WHO) Expert Committee on Food Additives. WHO Technical Report Series No. 617. WHO, Geneva, Switzerland.
73. Joint Expert Committee on Food Additives (JECFA) (1980). Evaluation of Certain Food Additives and Contaminants. 24th Report of the Joint Food and Agriculture Organization of the United Nations (FAO)/World Health Organization (WHO) Expert Committee on Food Additives. WHO Technical Report Series No. 653. WHO, Geneva, Switzerland.
74. Joint Expert Committee on Food Additives (JECFA) (1981). Toxicological Evaluation of Certain Food Additives and Contaminants. 25th Report of the Joint Food and Agriculture Organization of the United Nations (FAO)/World Health Organization (WHO) Expert Committee on Food Additives. WHO Food Additives Series No. 16, WHO Technical Report Series No. 669. WHO, International Programme on Chemical Safety (IPCS), Geneva, Switzerland.
75. Joint Expert Committee on Food Additives (JECFA) (1982). Evaluation of Certain Food Additives and Contaminants. 26th Report of the Joint Food and Agriculture Organization of the United Nations (FAO)/World Health Organization (WHO) Expert Committee on Food Additives. WHO Technical Report Series No. 683. WHO, International Programme on Chemical Safety (IPCS), Geneva, Switzerland.
76. Joint Expert Committee on Food Additives (JECFA) (1983). Toxicological Evaluation of Certain Food Additives and Contaminants. 27th Report of the Joint Food and Agriculture Organization of the United Nations (FAO)/World Health Organization (WHO) Expert Committee on Food Additives. WHO Food Additives Series No. 18, WHO Technical Report Series No. 696. WHO, International Programme on Chemical Safety (IPCS), Geneva, Switzerland.
77. Joint Expert Committee on Food Additives (JECFA) (1987a). Toxicological Evaluation of Certain Food Additives and Contaminants. 30th Meeting of the Joint Food and Agriculture Organization of the United Nations (FAO)/World Health Organization (WHO) Expert Committee on Food Additives. WHO Food Additives Series No. 21. WHO, International Programme on Chemical Safety (IPCS), Geneva, Switzerland.
78. Joint Expert Committee on Food Additives (JECFA) (1987b). Toxicological Evaluation of Certain Food Additives and Contaminants. 29th Meeting of the Joint Food and Agriculture Organization of the United Nations (FAO)/World Health Organization (WHO) Expert Committee on Food Additives. WHO Food Additives Series No. 20. WHO, International Programme on Chemical Safety (IPCS), Geneva, Switzerland.
79. Joint Expert Committee on Food Additives (JECFA) (1989). Toxicological Evaluation of Certain Food Additives and Contaminants. 33rd Meeting of the Joint Food and Agriculture Organization of the United Nations (FAO)/World Health Organization (WHO) Expert Committee on Food Additives. WHO Food Additives Series No. 24. WHO, International Programme on Chemical Safety (IPCS), Geneva, Switzerland.
80. Joint Expert Committee on Food Additives (JECFA) (1993). Toxicological Evaluation of Certain Food Additives and Contaminants. 41st Meeting of the Joint Food and Agriculture Organization of the United Nations (FAO)/World Health Organization (WHO) Expert Committee on Food Additives. WHO Food Additives Series No. 32, WHO Technical Report Series No. 837. WHO, International Programme on Chemical Safety (IPCS), Geneva, Switzerland.
81. Kannan, R., Grant, N., Aunis, D., and Langley, K. (1996). SNAP-25 is differentially expressed in noradrenergic and adrenergic chromaffin cells. FEBS Lett. 385, 159-164.
82. Kearsley, M. W., Birch, G. G., and Lian-Loh, R. H. P. (1982). The metabolic fate of hydrogenated glucose syrups. Stärche 34, 279-283. [Cited in JECFA, 1987b]
83. Keup, U., and Putter, J. (1974). Serumglukose-und-insulinverlauf bei gesunden Probanden nach einmaliger oraler Palatinit-bzw. Saccharosebeiastung. Bayer, A. G. Pharma-Bericht Nr 4781 v.1.4.1974. Unpublished report submitted to WHO by Bayer, A. G. [Cited in JECFA, 1981]
84. Kocian, J., Skala, I., and Bakos, K. (1973). Calcium absorption from milk and lactose-free milk in healthy subjects and patients with lactose intolerance. Digestion 9, 317-324.
85. Kurokawa, Y., Hayashi, Y., Maekawa, A., Takahashi, M., and Kukubo, T. (1985). High incidences of pheochromocytomas after long-term administration of retinol acetate to F344/DuCrj rats. J. Natl. Cancer Inst. 74(3), 715-723.
86. Langkilde, A. M., Andersson, H., Schweizer, T. F., and Wursch, P. (1994). Digestion and absorption of sorbitol, maltitol and isomalt from the small bowel. A study in ileostomy subjects. Eur. J. Clin. Nutr. 48, 768-775.
87. Léon, C., Grant, N. J., Aunis, D., and Langley, K. (1992). Expression of cell adhesion molecules and catecholamine synthesizing enzymes in the developing rat adrenal gland. Dev. Brain Res. 70, 109-121.
88. Mäkinen, K. K., and Virtanen, K. K. (1978). J. Dent. Res. 57, 441. [Cited in Mäkinen et al., 1981]
89. Mäkinen, K. K., Ylikahri, R., Mäkinen, P. L., Söderling, E., and Hämäläinen, M. (1981). Turku sugar studies XXIII. Comparison of metabolic tolerance in human volunteers to high oral doses of xylitol and sucrose after long-term regular consumption of xylitol. In Xylitol. Clinical Investigations in Humans (O. Raunhardt and G. Ritzel, Eds.), Suppl. No. 22, pp. 29-51. International Journal for Vitamin and Nutrition Research. Hans Huber Publishers, Bern.
90. Malhanthappa, N. K., Gage, F. H., and Patterson, P. H. (1990). Adrenal chromaffin cells as multipotential neurons for autografts. Prog. Brain Res. 82, 33-39.
91. Malhotra, R. K., Wakade, T. D., and Wakade, A. R. (1989). Cross-communication between acetylcholine and VIP in controlling catecholamine secretion by affecting cAMP, inositol triphosphate, protein kinase C and calcium in rat adrenal. J. Neurosci. 9, 4150-4157.
92. Manger, W. M., Gifford, R. W., Jr., and Hoffman, B. B. (1985). Pheochromocytoma: A clinical and experimental overview. Curr. Prob. Cancer 9, 1-89.
93. Mills, R., Breiter, H., Kempster, E., McKey, B., Pickens, M., and Outhouse, J. (1940). The influence of lactose on calcium retention in children. J. Nutr. 20, 467-476.
94. Minno, A. M., Bennett, W. A., and Kvale, W. F. (1954). Pheochromocytoma: A study of 15 cases diagnosed at autopsy. N. Engl. J. Med. 251, 959-965. [Cited in Manger et al., 1985]
95. Modderman, J. P. (1993). Safety assessment of hydrogenated starch hydrolysates. Regul. Toxicol. Pharmacol. 18, 80-114.
96. Mosher, A. H., and Kircher, C. H. (1988). Proliferative lesions of the adrenal medulla in rats treated with zomepirac sodium. J. Am. Coll. Toxicol. 7(1), 83-93.
97. 1 Mice (Feed Study), NTP Technical Report Series No. 236. National Toxicology Program, U.S. Department of Health and Human Services.
98. Nguyen, N. U., Dumoulin, G., Henriet, G., Berthelay, S., and Regnard, J. (1993). Carbohydrate metabolism and urinary excretion of calcium and oxalate after ingestion of polyol sweeteners. J. Clin. Endocrinol. Metab. 77, 388-392.
99. Nilsson, U., and Jagerstad, M. (1987). Hydrolysis of lactitol, maltitol and Palatinit by human intestinal biopsies. Br. J. Nutr. 58, 199-206.
100. Pansu, D., Chapuy, M. C., Milani, M., and Bellaton, C. (1975). Transepithelial calcium transport enhanced by xylose and glucose in the rat jejunal ligated loop. Calcif. Tissue Res. Suppl., 45-52.
101. Parker, T. L., Kesse, W. K., Mohamed, A. A., and Affwork, M. (1993). The innervation of the mammalian adrenal gland. J. Anat. 183, 265-276.
102. Pollard, M., and Luckert, P. H. (1989). Spontaneous diseases in aging Lobund-Wistar rats. In Dietary Restriction and Aging (D. L. Snyder, Ed.). A. R. Liss, New York. [Symposium on the Effects of Dietary Restriction on Aging and Disease in Germfree and Conventional Lobund-Wistar Rats - Proceedings, March 27-29, 1988, Notre Dame, IN, Vol. 287, pp. 51-60]
103. Powis, D. A., and Clark, C. L. (1995). Lanthanum reveals a difference in the mechanism for noradrenalin and adrenalin, p. 85. Abstracts of the 8th International Symposium on Chromaffin Cell Biology, Edinburgh, UK.
104. Putter, J., and Spengler, M. (1975). Zur Vertraglichkeit von Palatinit (Bay; 3930) als Einzeldosis Bayer AG Pharma-bericht Nr. 5475 v.6.6.1975. Unpublished report submitted to WHO by Bayer, A. G. [Cited in JECFA, 1981]
105. Roe, F. J. C. (1989). Relevance for man of the effects of lactose, polyols and other carbohydrates on calcium metabolism seen in rats: A review. Hum. Toxicol. 8, 87-98.
106. Roe, F. J. C., and Bär, A. (1985). Enzootic and epizootic adrenal medullary proliferative disease of rats: Influence of dietary factors which affect calcium absorption. Hum. Toxicol. 4(1), 27-52.
107. Saatman, R. A., DeBaecke, P. J., Streett, C. S., Malya, P. A. G., Hubben, K., Yeh, C., Enold, G. L., and McCurdy, D. H. (1978). Mannitol: A Lifetime Feeding Study in Rats. Part I. Report of ICI Americas Inc., Wilmington, DE. [Cited in FASEB, 1986]
108. Schardein, J. L., et al. (1968). Spontaneous tumors in Holtzman Source rats of various ages. Pathol. Vet. 5, 238-252. [Cited in Thompson et al., 1981]
109. Scheinin, A., and Mäkinen, K. K. (1975). Turku Sugar Studies I-XXI. Acta Odontol. Scand. 33(70), 1-348. [Cited in Bär, 1987a]
110. Schober, M., Fischer-Colbrie, R., Schmid, K. W., et al. (1987). Comparison of chromogranins A, B, and secretogranin II in human adrenal medulla and pheochromocytoma. Lab. Invest. 57, 385-391.
111. Secchi, A., Pontiroli, A. E., and Pozza, G. (1982). Influence of maltitol (Malbit®) on glycemia and insulinemia after oral administration. Unpublished report from Clinica Medica, Università di Malano, Italy. [Submitted to WHO by Anic, S.p.A. Cited in JECFA, 1987b]
112. Sher, S. P., Jensen, R. D., and Bokelman, D. L. (1982). Spontaneous tumors in control F344 and Charles River-CD rats and Charles River-CD-1 and B6C3F1 mice. Toxicol. Lett. 11, 103-110.
113. Siebert, G., Grupp, U., and Heinkel, K. (1975). Studies on isomaltitol. Nutr. Metabol. 18(Suppl. 1), 191-196. [Cited in JECFA, 1987b]
114. Sietzen, M., Schober, M., Fischer-Colbrie, R., Scherman, D., Sperk, G., and Winkler, H. (1987). Rat adrenal medulla. Levels of chromogranins, enkephalins, dopamine beta-hydroxylase and the amine transporter are changed by nervous activity and hypophysectomy. Neuroscience 22, 131-139.
115. Sinkeldam, E. J., Von Garderen-Hoetmer, A., and Woutersen, R. A. (1983). Life-span oral toxicity and carcinogenicity study with lactitol in rats pre-treated in utero, Report No. V 82.255. CIVO-TNO Institute, Zeist, The Netherlands.
116. Sinkeldam, E. J., Woutersen, R. A., Hollanders, V. M. H., Til, H. P., Van Garderen-Hoetmer, A., and Bär, A. (1992). Subchronic and chronic toxicity/carcinogenicity feeding studies with lactitol in rats. J. Am. Coll. Toxicol. 11, 165-188.
117. Smits-Van Prooije, A. E., de Groot, A. P., Dreef-Van der Meulen, H. C., and Sinkeldam, E. J. (1990). Chronic toxicity and carcinogenicity study of isomalt in rats and mice. Food Chem. Toxicol. 28(4), 243-251.
118. Spengler, M. (1978). Palatinit, tolerance test carried out at the Children's Clinic, City Hospital, Wuppertal-Bärmen Report 5.7.1978. Unpublished report submitted to WHO by Bayer, A. G. [Cited in JECFA, 1981]
119. Spengler, M., and Schmitz, H. (1979). Vergleich der Palatinit-Toleranz gegenuber der Sorbit-Toleranz gesunder Erwachsener nach 14-tagiger oraler Gabe Bayer AG Pharma-Bericht Nr. 8449 v.23.5.1979. Unpublished report submitted by Bayer, A. G. [Cited in JECFA, 1981]
120. Strandberg, J. D. (1983). Hyperplasia: Adrenal medulla, rat and pheochromocytoma adrenal medulla, rat. In Endocrine System (T. C. Jones, U. Mohr, and R. D. Hunt, Eds.). Springer-Verlag, New York. [Monographs on pathology of laboratory animals copy chapter]
121. Symington, T. (1969). Functional Pathology of the Human Adrenal Gland, pp. 215-324. Livingstone, London. [Cited in Thompson et al., 1981]
122. Tacquet, A., and Devulder, A. B. (1978). Study of the clinical and biological tolerance of Lycasin® 80/55 in man. Unpublished report from Hôpital Calmette, Lille, France. [Submitted to WHO by Roquette Freres. Cited in JECFA, 1987b]
123. Takizawa, Y., and Hachiya, N. (1984). Bacterial reversion assay and micronucleus test carried out on hydrogenated glucose syrups "Malti-Towa" (powder) and maltitol crystal. Mutat. Res. 137(2-3), 133-137.
124. Thompson, S. W., Rac, V. S., Semonick, D. E., Antonchak, B., Spaet, R. H., and Schellhammer, L. E., Jr. (1981). The Adrenal Medulla of Rats: Comparative Physiology, Histology, and Pathology, pp. 102. Charles C. Thomas, Springfield, IL.
125. Til, H. P., Feron, V. J., Immel, H. R., and Vogel, W. F. (1986). Chronic (89 week) feeding study with hydroxypropyl distarch phosphate, starch acetate, lactose and sodium alginate in mice. Food Chem. Toxicol. 24, 825-834.
126. Til, H. P., Hollanders, V. M. H., Woutersen, R. A., and Bar, A. (1992). Chronic toxicity and carcinogenicity study of lactitol in mice. J. Am. Coll. Toxicol. 11(2), 209-217.
127. Tischler, A. S., and Coupland, R. E. (1994). Changes in structure and function of the adrenal medulla. In Pathobiology of the Aging Rat (U. Mohr, D. L. Dungworth, and C. C. Capen, Eds.), Vol. 2, pp. 245-268. ILSI Press, Washington, DC.
128. Tischler, A. S., and DeLellis, R. A. (1988a). The rat adrenal medulla. I. The normal adrenal. J. Am. Coll. Toxicol. 7(1), 118.
129. Tischler, A. S., and DeLellis, R. A. (1988b). The rat adrenal medulla II. Proliferative lesions. J. Am. Coll. Toxicol. 7(1), 23-41.
130. Tischler, A. S., and Riseberg, J. (1993). Different responses to mitogenic agents by adult rat and human chromaffin cells in vitro. Endocrinol. Pathol. 4(1), 15-19.
131. Tischler, A. S., and Sheldon, W. (1995). The adrenal medulla in the aging mouse. In Pathobiology of the Aging Mouse. ILSI Monographs on the Pathobiology of Aging Animals (U. Mohr, D. L. Dungworth, and C. C. Capen, Eds.). ILSI Press, Washington, DC.
132. Tischler, A. S., DeLellis, R. A., Perlman, R. L., Allen, J. M., Costopoulos, D., Lee, Y. C., Nunnemacher, G., Wolfe, H. J., and Bloom, S. R. (1985). Spontaneous proliferative lesions of the adrenal medulla in aging Long-Evans rats: Comparison to PC12 cells, small granule-containing cells, and human adrenal medullary hyperplasia. Lab. Invest. 53, 486-498.
133. Tischler, A. S., Ruzicka, L. A., Donahue, S. R., and DeLellis, R. A. (1989). Chromaffin cell proliferation in the adult rat adrenal medulla. Int. J. Dev. Neurosci. 7, 439-448.
134. Tischler, A. S., McClain, R. M., Childers, H., and Downing, J. (1991). Neurogenic signals regulate chromaffin cell proliferation and mediate the mitogenic effect of reserpine in the adult rat adrenal medulla. Lab. Invest. 65(3), 374-376.
135. Tischler, A. S., Riseberg, J. C., Hardenbrook, M. A., and Van Cherington (1993). Nerve growth factor is a potent inducer of proliferation and neuronal differentiation for adult rat chromaffin cells in vitro. J. Neurosci. 13(4), 1533-1542.
136. Tischler, A. S., Riseberg, J. C., and Van Cherington (1994). Multiple mitogenic signaling pathways in chromaffin cells: A model for cell cycle regulation in the nervous system. Neurosci. Lett. 168, 181-184.
137. Tischler, A. S., Riseberg, J. C., and Gray, R. (1995). Mitogenic and antimitogenic effects of pituitary adenylate cyclase-activating polypeptide (PACAP) in adult rat chromaffin cells. Neurosci. Lett. 189, 135-138.
138. 3, lactose and xylitol stimulate chromaffin cell proliferation in the rat adrenal medulla. Toxicol. Appl. Pharmacol., in press.
139. Tomlinson, A., and Coupland, R. E. (1990). The innervation of the adrenal gland. IV. Innervation of the rat adrenal medulla from birth to old age. A descriptive and quantitative morphometric and histochemical study of the innervation of chromaffin cells and adrenal medullary neurons in Wistar rats. J. Anat. 169, 209-236. [Cited in Tischler and Coupland, 1994]
140. Vitale, N., Aunis, D., and Bader, M-F. (1995). GAP-43 controls the recruitment of secretory granules for exocytosis by stimulating the granule-associated G°, p. 56. Abstracts of the 8th International Symposium on Chromaffin cell Biology, Edinburgh, UK.
141. von Schlegel, G. G. (1960). Neurofibromatose Recklinghausen und Phäochromocytom. Schweiz. Med. Wochenshr. 90, 31-39. [Cited in Manger et al., 1985]
142. Watanabe, T., Masuo, Y., Matsumoto, H., Suzuki, N., Ohtake, T., Masuda, Y., Kitadu, C., and Fujino, M. (1992). Pituitary adenylate cyclase activating polypeptide provokes cultured rat chromaffin cells to secrete adrenaline. Biochem. Biophys. Res. Commun. 182, 403-411. [Cited in Tischler et al., 1994]
143. Winkler, H., Apps, D. K., and Fischer-Colbrie, R. (1986). The molecular function of adrenal chromaffin granules: Established facts and unresolved topics. Neuroscience 18, 261-290. [Cited in Tischler and DeLellis, 1988a]
144. Woutersen, R. A. (1987). Chronic toxicity and carcinogenicity of lactitol in rats: Comparison with lactose. In Low Digestibility Carbohydrates (B. C. Leegwater, V. G. Feron, and R. J. J. Hermuns, Eds.), pp. 51-60. Pudoc, Wageningen, FRG.
145. Yarrington, T. J., and Johnston, J. O. (1994). Aging in the adrenal cortex. In Pathobiology of the Aging Rat, Volume 2 (U. Mohr, D. L. Dungworth, and C. C. Capen, Eds.), pp. 127-244. ILSI Press, Washington, DC.
146. Zaal, J., and Ottenhof, A. (1977). Influence of lactitol in blood sugar levels after sucrose intake. Unpublished report by CIVO-TNO. [Submitted by CCA to WHO. Cited in JECFA, 1983]